Intravenous therapy solutions market seen reaching $21.25 billion by 2030

The intravenous therapy solutions market is projected to rise from $13.17 billion in 2025 to $21.25 billion by 2030, according to a new Business Research Company report. Growth is being driven by hospital expansion, rising chronic disease care, home healthcare adoption and broader use of minimally invasive procedures.

Why it matters: - Intravenous therapy solutions are becoming more important as healthcare systems need faster delivery of fluids, medications, nutrients and electrolytes. - The market’s projected jump to $21.25 billion by 2030 signals sustained demand across hospitals, clinical care and home-based treatment. - The trend also points to broader adoption of infusion-based care in chronic disease management and minimally invasive procedures.

What happened: - The Business Research Company released a report on the intravenous therapy solutions market with forecasts through 2030. - The market is estimated at $13.17 billion in 2025 and expected to reach $14.53 billion in 2026. - The report projects the market will grow at a 10.3% CAGR in the historical period and 10.0% during the forecast period. - North America held the largest share of the global market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available. - A full market report is also available.

The details: - Historical growth was tied to hospital infrastructure expansion, more dehydration and electrolyte imbalance cases, wider clinical adoption of IV therapy, technological advances and higher surgical volumes. - Future growth is expected to come from home healthcare services, personalized nutrition and medication delivery, digital health integration, emerging market expansion and chronic disease care. - The report highlights personalized IV therapy, portable and home-based infusion devices, stronger infection control, advanced electrolyte and nutrient formulations, and tighter electronic health record integration as major trends. - Intravenous therapy solutions are sterile liquid formulations delivered directly into a vein. - The solutions are used to treat dehydration, electrolyte imbalances, infections and nutritional deficiencies when oral intake is not enough. - Common ingredients include water, salts, sugars or medicinal compounds tailored to patient needs. - The report’s 2026 version adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The report frames IV therapy as a market shaped by two care models at once: higher-acuity hospital treatment and more decentralized home-based care. - The emphasis on digital health, EHR integration and portable devices suggests infusion therapy is moving closer to connected, outpatient workflows. - The cited rise in minimally invasive procedures underscores why IV support remains essential even as surgery becomes less invasive. - Data from the American Society of Plastic Surgeons showed minimally invasive procedures rose 7% in 2023, outpacing traditional surgical interventions by 2%.

What's next: - The market is expected to keep expanding as healthcare providers lean more on infusion therapies for chronic disease management and personalized treatment. - Emerging economies in Asia-Pacific are expected to post faster growth than North America. - Product development is likely to focus on home-use devices, infection prevention and more customized infusion formulations.

The bottom line: - IV therapy solutions are moving from a hospital staple to a broader care platform, and the market outlook reflects that shift.